FRANCO, Renato
 Distribuzione geografica
Continente #
NA - Nord America 6.550
EU - Europa 6.302
AS - Asia 1.190
SA - Sud America 22
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 14.096
Nazione #
US - Stati Uniti d'America 6.426
IE - Irlanda 2.169
IT - Italia 1.045
UA - Ucraina 893
GB - Regno Unito 747
SG - Singapore 469
DE - Germania 391
CN - Cina 380
FR - Francia 316
GR - Grecia 250
TR - Turchia 238
FI - Finlandia 234
SE - Svezia 145
CA - Canada 119
BE - Belgio 32
KR - Corea 27
VN - Vietnam 19
BR - Brasile 17
NL - Olanda 16
PK - Pakistan 13
ES - Italia 12
RS - Serbia 11
EU - Europa 10
HK - Hong Kong 9
TW - Taiwan 9
MK - Macedonia 8
AT - Austria 7
CZ - Repubblica Ceca 7
PH - Filippine 7
CH - Svizzera 6
AU - Australia 5
BJ - Benin 5
DZ - Algeria 5
IN - India 5
IR - Iran 5
MA - Marocco 5
MX - Messico 4
AR - Argentina 3
BG - Bulgaria 3
PL - Polonia 3
IL - Israele 2
LT - Lituania 2
PE - Perù 2
RU - Federazione Russa 2
TH - Thailandia 2
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KG - Kirghizistan 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
SV - El Salvador 1
ZA - Sudafrica 1
Totale 14.096
Città #
Dublin 2.157
Santa Clara 1.434
Jacksonville 1.368
Chandler 810
Princeton 329
Roxbury 286
Singapore 281
Medford 255
Naples 193
Wilmington 160
Bremen 133
Beijing 131
Ann Arbor 124
Caserta 111
Des Moines 104
Elora 98
Woodbridge 87
Boardman 79
New York 79
Cambridge 78
Napoli 62
San Mateo 56
Ashburn 54
Munich 53
Nanjing 42
Düsseldorf 40
Mountain View 40
Ercolano 37
Brussels 31
Houston 26
Aversa 25
Seoul 24
Jinan 22
Dong Ket 18
Milan 18
Nanchang 18
Auburn Hills 17
Norwalk 17
Los Angeles 16
Helsinki 15
Istanbul 15
Kunming 15
Redwood City 15
Rome 15
Shenyang 15
Falls Church 14
London 14
Seattle 14
Tianjin 14
Venice 13
Belgrade 10
Shanghai 10
Guangzhou 9
Hong Kong 9
Lappeenranta 9
Taipei 9
Toronto 8
Zhengzhou 8
Amsterdam 7
Brno 7
Changsha 7
Hebei 7
Stuttgart 7
Torre Del Greco 7
Acerra 6
Clifton 6
Fairfield 6
Lausanne 6
Mcallen 6
Menlo Park 6
Montesarchio 6
Ottawa 6
Pozzuoli 6
Rimini 6
San Giuliano 6
Atlanta 5
Groningen 5
Haikou 5
Hangzhou 5
Samsun 5
Scafati 5
Vienna 5
Bari 4
Berlin 4
Castello di Brianza 4
Duncan 4
Frankfurt am Main 4
Lanzhou 4
Paris 4
Petruro Irpino 4
Pontecagnano 4
Salerno 4
Seregno 4
Afragola 3
Avellino 3
Chieti 3
Colle di Val d'Elsa 3
Federal 3
Florence 3
Giugliano in Campania 3
Totale 9.352
Nome #
Anatomia Patologica dei vasi 111
Impiego di ligandi di natura peptidica e non peptidica del recettore UT dell'Urotensina-II quali marcatori di differenziazione del carcinoma prostatico umano. 98
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage 96
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 86
Large single cutaneous metastasis of colon adenocarcinoma mimicking a squamous cell carcinoma of the skin: A case report 85
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 85
High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness 84
Predictive biomarkers along gastric cancer pathogenetic pathways 83
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 81
Histopathological pattern of lymph-node metastases from Oral Squamous Cell Carcinoma. An unicentric retrospective study on 146 neck dissections. 75
Aurora B Expression in Post-Puberal Testicular Germ Cell Tumours 73
The role of tissue microarray in the era of target-based agents. 70
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors 70
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 68
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 68
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 67
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 67
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC? 66
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 65
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 65
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 65
Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers 64
Renal cell carcinoma with solitary toe metastasis 64
Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. 62
Detection of High Mobility Group Proteins A1 and A2 represents a valid diagnostic marker in Post-Puberal Testicular Germ Cell Tumors. 62
Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy 61
A rare case of malignant solitary fibrous tumor in prostate with review of the literature 61
Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers 61
Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line 60
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 60
NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? 59
Synchronus primary adenocarcinoma and adenosquamous carcinoma of the esophagus 59
CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. 59
Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas 59
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 59
HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer 58
Deregulation of HOX B13 expression in urinary bladder cancer progression 58
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome 58
The use of ultrasound in detecting and defining ground-glass opacities: results of an ex vivo evaluation 58
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 58
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 58
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 58
Novel medicinal mushroom blend as a promising supplement in integrative oncology: A multi-tiered study using 4t1 triple-negative mouse breast cancer model 57
Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations 57
Kidney Transplant Modifies the Architecture and Microenvironment of Basal Cell Carcinomas 57
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 57
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 57
WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors 56
PEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations 56
DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck 56
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 56
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 56
Use of non peptidic and peptidic ligands or immunodetection of the receptor for urotensin II for the definition of both differentiation and prognosis of human prostate adenocrarcinoma 55
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 55
A new look at the ALK gene in cancer: copy number gain and amplification 55
A 52-year-old man with a mass in the perineal region. Perineurioma. 54
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: Current evidence and future perspectives 54
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 54
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 54
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. 53
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 53
Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas 53
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 53
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 53
ESTRADIOL-INDUCED MAP KINASE (ERK1/2) ACTIVITY IN THE FROG (RANA ESCULENTA) TESTIS 52
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 52
Basal Cell Carcinoma: Molecular and Pathological Features 52
BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy 51
Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer 51
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 51
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 51
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 51
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype 51
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 51
Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy? 51
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 50
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence. 50
De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats 50
CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression 50
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 50
Prok1/ProkR1 expression in testis germ cell tumors: study of 90 cases in a tissue micro-array 50
A case of Melkersson–Rosenthal syndrome successfully treated with hydroxychloroquine 50
EGFR mutational status in penile cancer. 49
Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3 49
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 49
Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5 49
Atypical amplification of chromosome region 22q12 in melanoma: A case report 49
TLR4 down-regulation identifies high risk HPV integration in head and neck squamous cell carcinomas 49
Sigmoid metastasis from endometrioid cancer 49
Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: Management of cytological sample by an integrated approach 49
Malignant extrapleural solitary fibrous tumor arising in the sublingual gland: A case report and review of literature 49
Human melanoma metastases express functional CXCR4. 48
Differential role of CD133 and CXCR4 in renal cell carcinoma 48
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. 48
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma 48
SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression 48
B-cell lymphoblastic lymphoma presenting as solitary temporal mass with amplification of AML1/RUNX1: Case report 48
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 48
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 48
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 48
Totale 5.882
Categoria #
all - tutte 74.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020673 0 0 0 0 0 23 304 78 84 82 70 32
2020/20211.977 82 12 260 66 311 25 274 228 69 299 279 72
2021/20222.095 66 36 28 30 697 18 56 71 89 165 195 644
2022/20233.631 488 96 54 259 313 242 10 158 1.868 29 51 63
2023/20241.600 114 60 60 91 605 107 48 48 31 24 105 307
2024/20252.100 39 50 52 107 965 887 0 0 0 0 0 0
Totale 14.789